Elevance Health Names Amy Schulman Independent Director Effective January 12, 2026
Elevance Health's board elected Amy W. Schulman as an independent director, effective January 12, 2026, with a term expiring at the 2028 annual meeting. She was also appointed to the Audit and Finance Committees, and the board determined she qualifies as an audit committee financial expert. The filing reports no financial results, and the appointment is a board governance change rather than a change to the company's operations.
Key points
- Amy W. Schulman elected independent director by the Board on December 10, 2025, effective January 12, 2026
- Term expires at the Company's 2028 annual meeting of shareholders
- Appointed to the Audit and Finance Committees; Board determined she qualifies as an audit committee financial expert
- Ms. Schulman's director compensation follows the standard non-employee director program
The filing
Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 10, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.